Related Experiment Video
Updated: Jun 18, 2025

2D and 3D Human Induced Pluripotent Stem Cell-Based Models to Dissect Primary Cilium Involvement during Neocortical Development
Published on: March 25, 2022
RAB12-LRRK2 Complex Suppresses Primary Ciliogenesis and Regulates Centrosome Homeostasis in Astrocytes
Xingjian Li1,2, Hanwen Zhu3, Bik Tzu Huang1,4,5
1Department of Neurology, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract:
Leucine-rich repeat kinase 2 (LRRK2) phosphorylates a subset of RAB GTPases, and the phosphorylation levels are elevated by Parkinson's disease (PD)-linked mutations of LRRK2. However, the precise function of the specific RAB GTPase targeted by LRRK2 signaling in the brain remains to be elucidated. Here, we identify RAB12 as a robust LRRK2 substrate in the mouse brains through phosphoproteomics profiling and solve the structure of RAB12-LRRK2 protein complex through Cryo-EM analysis. Mechanistically, RAB12 cooperates with LRRK2 to inhibit primary ciliogenesis and regulate centrosome homeostasis in astrocytes through enhancing the phosphorylation of RAB10 and recruiting Rab interacting lysosomal protein like 1 (RILPL1), while the functions of RAB12 require a direct interaction with LRRK2 and LRRK2 kinase activity. Furthermore, the ciliary deficits and centrosome alteration caused by the PD-linked LRRK2-G2019S mutation are prevented by the deletion of Rab12 in astrocytes. Thus, our study reveals a physiological function of the RAB12-LRRK2 complex in regulating ciliogenesis and centrosome homeostasis. The RAB12-LRRK2 structure offers a guidance in the therapeutic development of PD by targeting the RAB12-LRRK2 interaction.
Insights
Researchers identified RAB12 as a key target of Leucine-rich repeat kinase 2 (LRRK2) in the brain. This interaction regulates cell structure, offering new therapeutic targets for Parkinson's disease (PD).
Area of Science:
- Cell Biology
- Neuroscience
- Structural Biology
Background:
- Leucine-rich repeat kinase 2 (LRRK2) is implicated in Parkinson's disease (PD) through its phosphorylation of RAB GTPases.
- The specific roles of LRRK2-phosphorylated RAB GTPases in brain function, particularly in relation to PD, are not fully understood.
Purpose of the Study:
- To identify novel LRRK2 substrates in the brain.
- To elucidate the function of the RAB12-LRRK2 complex in regulating ciliogenesis and centrosome homeostasis.
- To provide structural insights into the RAB12-LRRK2 interaction for therapeutic development.
Main Methods:
- Phosphoproteomics profiling to identify LRRK2 substrates in mouse brains.
- Cryo-electron microscopy (Cryo-EM) to determine the structure of the RAB12-LRRK2 protein complex.
- Genetic manipulation (gene deletion) in astrocytes to assess functional consequences.
Main Results:
- RAB12 was identified as a direct substrate of LRRK2 in mouse brains.
- The RAB12-LRRK2 complex inhibits primary ciliogenesis and regulates centrosome homeostasis in astrocytes.
- This regulation involves RAB10 phosphorylation and Rab interacting lysosomal protein like 1 (RILPL1) recruitment.
- PD-linked LRRK2 mutations' effects on cilia and centrosomes were ameliorated by RAB12 deletion.
Conclusions:
- The study reveals a novel physiological role for the RAB12-LRRK2 complex in ciliogenesis and centrosome homeostasis.
- The elucidated structure of the RAB12-LRRK2 complex provides a basis for developing therapeutics targeting PD by modulating this interaction.
More Related Videos
09:39Quantitative Immunofluorescence Assay to Measure the Variation in Protein Levels at Centrosomes
Published on: December 20, 2014
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
Related Concept Videos
Microtubules in Signaling
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity
Negative Regulator Molecules
Assembly of Complex Microtubule Structures